Seasoned executive brings decades of experience in AI-driven health, digital therapeutics, and payor strategy to support Rune Labs’ next phase of growth
Rune Labs, the leader in precision medicine for neurology, announced the appointment of Adam Pellegrini as an independent member of its Board of Directors. Pellegrini is a recognized leader in AI-driven digital health, with more than two decades of experience building and scaling platforms that bridge technology, patients, and healthcare systems. His background spans executive roles at Kaia Health, Jasper Health, CVS Health, Fitbit, Walgreens Boots Alliance, and other organizations that have shaped how digital tools support prevention, chronic disease management, and patient engagement.
Health Technology Insights: BioTek reMEDys Promotes Autoinflammatory Awareness
Pellegrini is currently serving as CEO of AI-based musculoskeletal and pulmonary company Kaia Health, expanding access through strategic partnerships and reimbursement pathways. Before Kaia, he served as CEO and Board Member of Jasper Health, which provides virtual oncology care and patient navigation solutions used by thousands of individuals and caregivers. Earlier in his career, he served as SVP Enterprise Virtual Care & Consumer Health Innovation at CVS Health and General Manager & SVP at Fitbit (now part of Google), helping drive payor integration and digital health strategies that advanced large-scale adoption across employers and health plans. Pellegrini also served as Digital Health Leader & Vice President Marketing for the American Cancer Society, driving digital strategy for the entire organization.
Health Technology Insights: Molecular Targeting Technologies Sues Over Unauthorized EB-TRT Use
“Adam has a unique understanding of how digital health can create real value across the care continuum,” said Brian Pepin, CEO of Rune Labs. “His experience scaling technology and building reimbursement partnerships over multiple sectors of healthcare will be invaluable as we expand the StrivePD ecosystem and strengthen our work with trial sponsors, clinicians, and payors.”
Pellegrini’s appointment comes as Rune Labs is experiencing significant growth of its StrivePD platform, which helps improve how PD is managed and studied. StrivePD brings together data from the Apple Watch, clinical sources, and self-reported outcomes using AI-driven analysis to improve care management, giving people with PD (PwPD) and providers a clearer view of daily symptoms and treatment responses while improving access to innovative therapies. StrivePD also enhances how PwPD are identified, recruited, and monitored in clinical trials, enabling sponsors to design more precise studies and reduce operational inefficiencies.
“Rune Labs is setting a new standard of care for how real-world data and digital tools drive innovation and results in neurological research and care, serving the entire ecosystem from individuals and clinicians to researchers, healthcare organizations, and payors,” said Pellegrini. “That kind of connected insight enables smarter decisions and supports more sustainable models of care.”
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 14 October 2025
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- businesswire
